Filing Details
- Accession Number:
- 0001415889-24-024665
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-03 18:03:39
- Reporting Period:
- 2024-10-01
- Accepted Time:
- 2024-10-03 18:03:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1484565 | Soleno Therapeutics Inc | SLNO | Electromedical & Electrotherapeutic Apparatus (3845) | 770523891 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1643441 | Kristen Yen | 100 Marine Parkway, Suite 400 Redwood City CA 94065 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-10-01 | 2,789 | $49.34 | 81,784 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-10-01 | 319 | $50.25 | 81,465 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- This transaction was executed in multiple trades at prices ranging from $48.95 to $49.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- This transaction was executed in multiple trades at prices ranging from $49.95 to $50.49. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.